BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Sanyou Biopharmaceuticals and TransRecoBio Form Strategic Alliance to Accelerate Innovative Formulation Development

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Biopharmaceuticals") and TransRecoBio (Wenzhou) Biotechnology Co., Ltd. ("TransRecoBio") officially...

May 14, 2025 | News

Hyundai ADM Bio Withdraws IND for Penetrium™/Docetaxel and Pivots to Immunotherapy Combinations

Hyundai ADM Bio announced the voluntary withdrawal of its Investigational New Drug (IND) application for Phase 1 clinical trial evaluating Pene...

May 14, 2025 | News

Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...

May 08, 2025 | News

Andelyn Biosciences Supports Nationwide Children's Novel AML Therapy with AAV Manufacturing

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has manufac...

May 08, 2025 | News

AGC Biologics Partners with South Korea’s Novelty Nobility to Advance Bispecific Antibody Program Across Europe and Asia

Global CDMO supports South Korean company on a multiphase project at its Copenhagen and Chiba sites AGC Biologics, your friendly CDMO expert, an...

May 06, 2025 | News

Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...

May 06, 2025 | News

PCI Pharma Services Acquires Ajinomoto Althea’s Altair to Build Global Powerhouse in Aseptic Filling and Advanced Drug Delivery

PCI Pharma Services ("PCI") is pleased to announce the launch of Ajinomoto Althea, the world's leading contract research and manufacturing organi...

May 05, 2025 | News

Lotte Biologics Seals First ADC Manufacturing Deal to Launch Full-Scale US Production

Lotte Biologics has announced the signing of its first official contract manufacturing agreement at its newly expanded antibody-drug conjugate (ADC) produc...

April 25, 2025 | News

Samsung Biologics Delivers KRW 1.3 Trillion Revenue in Q1 2025, Boosted by Plant 5 Launch and Expanding CDMO Contracts

Recorded Q1'25 consolidated revenue of KRW 1.3 trillion Recorded Q1'25 consolidated operating profit of KRW 486.7 billion Company expected to...

April 23, 2025 | News

WuXi Biologics Achieves Asia’s First Commercial PPQ Milestone with 3 x 5,000L Single-Use Bioreactors

- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,0...

April 21, 2025 | News

Porton Advanced Supports IND Approval of Tasly’s Dual-Targeting CAR-T Therapy for Recurrent Glioblastoma

Porton Advanced proudly announces its CDMO support for Tasly Pharmaceutical Co., Ltd.'s innovative CAR-T therapy, "P134 Cell Injection," which has received...

April 17, 2025 | News

Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program

Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...

April 16, 2025 | News

Shilpa Pharma’s Raichur Unit-2 in India Passes Second Straight FDA Inspection Without Observations

Shilpa Medicare announces that Shilpa Pharma Lifesciences – a wholly owned subsidiary – has successfully passed a U.S. Food and Drug Admin...

April 09, 2025 | News

AGC Biologics Sets New Benchmark in Japan With 5,000 L Single-Use Bioreactors at Yokohama CDMO Site

New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan AGC announced a strategic decision about the large-scale singl...

April 08, 2025 | News

Stay Connected